By Professor David Goldstein

Journal articles

Wong M; Goldstein D; Woo H; Testa G; Gurney H, 2002, 'α-interferon 2a and 13-cis-retinoic acid for the treatment of metastatic renal cell carcinoma', Internal Medicine Journal, 32, pp. 158 - 162, http://dx.doi.org/10.1046/j.1444-0903.2001.00184.x

Wong M; Goldstein D; Woo H; Testa G; Gurney H, 2002, 'Alpha-interferon 2a and 13-cis-retinoic acid for the treatment of metastatic renal cell carcinoma', Internal Medicine Journal, 32, pp. 158 - 162

Goldstein D; Thewes B; Butow P, 2002, 'Communicating in a multicultural society II: Greek community attitudes towards cancer in Australia', Internal Medicine Journal, 32, pp. 289 - 296

Marx GM; Boyce A; Goldstein D, 2002, 'Elevated alpha-foetoprotein and hepatic metastases - it`s not always what it seems!', Annals of Oncology, 13, pp. 167 - 169

Harrison ML; Goldstein D, 2002, 'Prolonged survival in a patient with an occult small-cell lung cancer and a solitary brain metastasis at diagnosis', Internal Medicine Journal, 32, pp. 621 - 622

Goldstein D; Margo J, 2001, 'Cancer in the bush - Optimising clinical services', Cancer Forum, 25, pp. 121 - 125

Eisenbruch IM; Barlow-Stewart K; Tucker K; Steel ZP; Goldstein D; Meiser B, 2001, 'Cultural aspects of cancer genetics: setting a research agenda', Journal of Medical Genetics, pp. 425 - 429

Ngan S; Burmeister B; Fisher R; Rischin D; Schache D; Kneebone A; Mackay J; Joseph D; Bell A; Goldstein D, 2001, 'Early Toxicity from Preoperative Radiotherapy with Continuous Infusion 5-Fluorouracil for Resectable Adenocarcinoma of the Rectum: A Phase II Trial for the Trans-Tasman Radiation', International Journal of Radiation Oncology and Biology Physics, pp. 883 - 887

Boyer MJ; Mitchell P; Goldstein D; Millward MJ; Olver IN; Clarke SJ; Richardson GD; Davis I, 2001, 'Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer', Lung Cancer, pp. 89 - 94

Herz H; Cooke B; Goldstein D, 2000, 'Metastatic secretory breast cancer. Non-responsiveness to chemotherapy: Case report and review of the literature', Annals of Oncology, 11, pp. 1343 - 1347, http://dx.doi.org/10.1023/A:1008387800525

Ngan SY; Burmeister BH; Fisher R; Rischin D; Schache DJ; Kneebone A; Mackay JR; Joseph DJ; Bell A; Goldstein D, 2000, 'A phase II trial of preoperative radiotherapy with protracted infusion 5-fluorouracil for resectable adenocarcinoma of rectum. A multi-center trial for the Trans-Tasman Radiation Oncology Group', International Journal of Radiation Oncology*Biology*Physics, 48, pp. 119 - 120, http://dx.doi.org/10.1016/s0360-3016(00)80035-8

Huang X; Butow PN; Meiser B; Goldstein D, 1999, 'Attitudes and information needs of Chinese migrant cancer patients and their relatives', Australian and New Zealand Journal of Medicine, 29, pp. 207 - 213, http://dx.doi.org/10.1111/j.1445-5994.1999.tb00685.x

Bishop JF; Dewar J; Toner GC; Smith J; Tattersall MHN; Olver IN; Ackland S; Kennedy I; Goldstein D; Gurney H; Walpole E; Levi J; Stephenson J; Canetta R, 1999, 'Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer', Journal of Clinical Oncology, 17, pp. 2355 - 2364, http://dx.doi.org/10.1200/jco.1999.17.8.2355

Davis AJ; Goldstein D; Milliken S, 1998, 'Long term follow-up of CEOP in the treatment of HIV related non- Hodgkin's lymphoma (NHL)', Australian and New Zealand Journal of Medicine, 28, pp. 28 - 32, http://dx.doi.org/10.1111/j.1445-5994.1998.tb04455.x

Newell ME; Milliken ST; Goldstein D; Lewis CR; Boyle MJ; Dolan G; Ryan S; Cooper DA; boyle , 1998, 'A phase 2 study of liposomal doxorubicin in the treatment of AIDS-related Kaposi¿s sarcoma', Australian and New Zealand Journal of Medicine, pp. 777 - 783

Goldstein D; Hertzog P; Tomkinson E; Couldwell D; Mccarville S; Parrish S; Cunningham PH; Newell ME; Owens M; Cooper DA, 1998, 'Administration of imiquimod, an interferon inducer, in asymptomatic human immunodeficiency virus-infected persons to determine safety and biologic response modification', Journal of Infectious Diseases, 178, pp. 856 - 861

Bishop JF; Dewar J; Toner GC; Tattersall MH; Olver IN; Ackland S; Kennedy I; Goldstein D; Gurney H; Walpole E; Levi J; Stephenson J, 1997, 'Paclitaxel as first-line treatment for metastatic breast cancer', ONCOLOGY, 11, pp. 19 - 23

Goldstein D; Pillay P; Hayman J; Leydman M, 1997, 'Association of hypercalcaemia, PTHrP expression and disease progression in a woman with primary squamous cell carcinoma of the breast.', Pathologe, pp. 317 - 319

Goldstein D; Douglas JR; Penny R; Matthews JP; Laidlaw CR; Gibson K; Bradstock KF; Wolf M, 1997, 'Australian leukaemia study group myeloma II: A randomised trial of intensive combination chemotherapy with or without interferon in patients with myeloma.', British Journal Haematology, pp. 38 - 45

Joshua D; Penny R; Matthews JP; Laidlawcr ; Gibson K; Bradstock KF; Wolf M; Goldstein D, 1997, 'Australian Leukaemia Study Group Myeloma II: a randomized trial of intensive comBination chemotherapy with or without interferon in patients with myeloma', British Journal of Haematology, pp. 38 - 45

Goldstein D; Butow P; Tattersall MH, 1997, 'Communication with cancer patients in culturally diverse Societies.', Annals of the New York Academy of Sciences, pp. 317 - 329

Goldstein D; Wolley I; Collett J, 1997, 'Diffuse alveolar damage following a singel adminstration of a cyclophosphamide containing chemotherapy regimen.', Australian and New Zealand Journal of Medicine, pp. 605 - 606

Goldstein D; Bishop J; Dewar J; Tattersall MH; Smith JS; Olver IN; Ackland S; Kennedy I; Toner GC; Gurney H; Walpole E; Levi J; Stephenson J, 1997, 'Paclitaxel as first line treatment for metastatic breast cancer.', Oncology, pp. 17 - 19

Padiglione A; Goldstein D; Law MG; Hoy JF; Kaldor JM; Mijch AM, 1997, 'Prognosis of Kaposi`s sarcoma as an initial and later AIDS associated illness', Annals of Oncology, pp. 871 - 875

Stricker P; Pryor K; Nicholson T; Goldstein D; Golovsky D; Ferguson R; Nash P; Ehsman S; Rumma J; Mammen G; Penny R, 1996, 'Bacillus Calmette-Guerin plus intravesical interferon alpha-2b in patients with superficial bladder cancer', Urology, 48, pp. 957 - 962, http://dx.doi.org/10.1016/S0090-4295(96)00375-5

Millar JL; Goldstein D; Gelmon KA, 1996, '5.14 HIV and Kaposi's sarcoma', Medical Journal of Australia, 164, pp. 539 - 542, http://dx.doi.org/10.5694/j.1326-5377.1996.tb122167.x

Boyle MJ; Goldstein DA; Frazer IH; Sculley TB, 1996, 'How HIV promotes malignancies', Medical Journal of Australia, 164, pp. 230 - 232, http://dx.doi.org/10.5694/j.1326-5377.1996.tb94147.x

Goebel F; Goldstein D; Goos M; Jablonowski H; Stewart JS, 1996, 'Efficacy and safety of stealth liposomal doxorubicin in AIDS-related Kaposi`s sarcoma', British Journal of Cancer, 73, pp. 989 - 994, http://dx.doi.org/10.1038/bjc.1996.193

Morton J; Taylor K; Bunce I; Eliadis P; Rentoul A; Moore D; Kelly C; Wright S; Bashford J; Rodwell R; Rooney K; Mulligan S; Firkin F; Dodds A; Parkin J; Lowenthal R; Kimber R; Frost T; Grigg A; Goldstein D; Stone J; Lee N, 1996, 'High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma', British Journal of Haematology, 95, pp. 110 - 115, http://dx.doi.org/10.1046/j.1365-2141.1996.d01-1868.x

Goldstein D, 1996, 'HIV associated malignancies', Hematology Reviews and Communications, 9, pp. 275 - 283

Dear AE; Goldstein D; Hayman JA, 1996, 'Malignant pulmonary lymphoid disease: Case reports illustrating anatomical pattern of disease as a prognostic marker', Pathology, 28, pp. 20 - 24, http://dx.doi.org/10.1080/00313029600169443

Newell M; Goldstein D; Milliken S; Lewis C; Hoy J; Thomson B; Cooper D, 1996, 'Phase I/II trial of filgrastim (r-metHuG-CSF), CEOP chemotherapy and antiretroviral therapy in HIV-related non-Hodgkin's lymphoma', Annals of Oncology, 7, pp. 1029 - 1036, http://dx.doi.org/10.1093/oxfordjournals.annonc.a010495

Millward MJ; Bishop JF; Friedlander M; Levi JA; Goldstein D; Olver IN; Smith JG; Toner GC; Rischin D; Bell DR, 1996, 'Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer', Journal of Clinical Oncology, 14, pp. 142 - 148, http://dx.doi.org/10.1200/JCO.1996.14.1.142

Nirenberg A; Meikle GR; Goldstein D; Meikle RG, 1995, 'Metastatic carcinoma infiltrating lung mimicking BOOP', Australasian Radiology, 39, pp. 405 - 407, http://dx.doi.org/10.1111/j.1440-1673.1995.tb00323.x

Pryor K; Goddard JD; Goldstein D; Stricker PD; Russell PJ; Golovsky D; Penny R, 1995, 'Bacillus Calmette-Guerein (BCG) enhances mobocyte-and lymphocyte-mediated bladder tumour cell killilng', British Journal of Cancer, 71, pp. 801 - 807, http://dx.doi.org/10.1038/bjc.1995.155

Dear A; Goldstein D; Salem H, 1995, 'pulmonary chronic lymphocytic leukaemia: difficulty in establishing a tissue diagnosis', European Journal of Haematology, pp. 130 - 133

FRIEDLANDER M; LEWIS C; GOLDSTEIN D, 1994, 'UNTITLED', MEDICAL JOURNAL OF AUSTRALIA, 161, pp. 638 - 638, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994PT68600027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tindall B; Forde S; Ross MW; Goldstein D; Barker S; Cooper DA, 1994, 'Effects of two formats of informed consent on knowledge amongst persons with advanced HIV disease in a clinical trial of didanosine', Patient Education and Counseling, 24, pp. 261 - 266, http://dx.doi.org/10.1016/0738-3991(94)90069-8

Kaldor J; Elford J; Grulich A; Goldstein D, 1994, 'HIV AIDS and cancer', Cancer Forum, 18, pp. 3 - 11

Tindall B; Forde S; Goldsten D; Ross MW; Cooper DA, 1994, 'Sexual dysfunction in advanced HIV disease', AIDS Care, 6, pp. 105 - 107, http://dx.doi.org/10.1080/09540129408258030

Mackintosh JF; Friedlander M; Lewis C; Goldstein D; Herrmann RP; Kearsley JH, 1994, 'Wanted: Guidelines for 'palliative' anti-cancer drug use [3]', Medical Journal of Australia, 161, pp. 638 - 639, http://dx.doi.org/10.5694/j.1326-5377.1994.tb127659.x

GOLDSTEIN D; MILLIKEN S NM; LEWIS C; HOY J; THOMSON B; DOLAN G; RYAN S; SARR A; COOPER DA, 1994, 'FILGRASTIM (r-metHuG-CSF, Amgen), CEOP AND ANTIRETROVIRAL THERAPY IN HIV- RELATED NON-HODGKINS LYMPHOMA (NHL)', AIDS, 8, pp. S46 - S46, http://dx.doi.org/10.1097/00002030-199411004-00179

D G; E T; D C; H G; M N; P H; M O; S M; S P; D H; D C, 1994, 'PHASE I A/B TRIAL OF IMIQUIMOD, AN ORAL INTERFERON INDUCER IN ASYMPTOMATIC HTV POSITIVE INDIVIDUALS', AIDS, 8, pp. S14 - S14, http://dx.doi.org/10.1097/00002030-199411004-00054

Tindall B; Carr A; Goldstein D; Penny R; Cooper DA, 1993, 'Administration of zidovudine during primary HIV-1 infection may be associated with a less vigorous immune response [1]', AIDS, 7, pp. 127 - 128, http://dx.doi.org/10.1097/00002030-199301000-00020

Lewis CR; Segelov E; Goldstein D; Friedlander ML, 1993, 'Chemotherapy made easier.', Australian and New Zealand journal of medicine, 23, pp. 387 - 392, http://dx.doi.org/10.1111/j.1445-5994.1993.tb01440.x

Nolten WE; Goldstein D; Lindstrom M; Mckenna MV; Carlson IH; Trump DL; Schiller J; Borden EC; Ehrlich EN, 1993, 'Effects of Cytokines on the Pituitary–Adrenal Axis in Cancer Patients', Journal of Interferon Research, 13, pp. 349 - 357, http://dx.doi.org/10.1089/jir.1993.13.349

Gibson DFC; Johnson DA; Goldstein D; Langan-Fahey SM; Borden EC; Jordan VC, 1993, 'Human recombinant interferon-βSER and tamoxifen: growth suppressive effects for the human breast carcinoma MCF-7 grown in the athymic mouse', Breast Cancer Research and Treatment, 25, pp. 141 - 150, http://dx.doi.org/10.1007/BF00662139

GOLDSTEIN D; KAUFMANN M, 1992, 'NOVEL APPROACHES TO THE MANAGEMENT OF GYNECOLOGIC MALIGNANCIES - CHAIRMENS PREFACE - PROCEEDINGS OF A SATELLITE SYMPOSIUM HELD IN CAIRNS, AUSTRALIA, ON 22 SEPTEMBER 1991', INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2, pp. 1 - 1, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1992KF21500001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Smalley RV; Goldstein D; Bulkowski D; Hannon C; Buchler D; Knudsen C; Tuttle RL, 1992, 'A phase II study of crisnatol mesylate in patients with ovarian carcinoma', Investigational New Drugs, 10, pp. 107 - 112, http://dx.doi.org/10.1007/BF00873127

Witt PL; Goldstein D; Storer BE; Grossberg SE; Flashner M; Colby CB; Borden EC, 1992, 'Absence of Biological Effects of Orally Administered Interferon-βser', Journal of Interferon Research, 12, pp. 411 - 413, http://dx.doi.org/10.1089/jir.1992.12.411

Back to profile page